1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Texas >
  6. Adnexus Biotechnologies Acquires Sanctum Therapeutics

M&A Deal Summary

Adnexus Biotechnologies Acquires Sanctum Therapeutics

On November 6, 2024, Adnexus Biotechnologies acquired life science company Sanctum Therapeutics

Acquisition Highlights
  • This is Adnexus Biotechnologies’ 1st transaction in the Life Science sector.
  • This is Adnexus Biotechnologies’ 1st transaction in the United States.
  • This is Adnexus Biotechnologies’ 1st transaction in Texas.

M&A Deal Summary
Date 2024-11-06
Target Sanctum Therapeutics
Sector Life Science
Buyer(s) Adnexus Biotechnologies
Deal Type Merger

Target

Sanctum Therapeutics

Missouri City, Texas, United States
Sanctum Therapeutics is a biotechnology company specializing in next-generation antiviral therapies. Sanctum Therapeutics is based in Missouri City, Texas.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Adnexus Biotechnologies

Dallas, Texas, United States
Category Company
Sector Life Science
DESCRIPTION

Adnexus Biotechnologies is an innovator in biotechnology, specializing in AI-driven solutions for early drug discovery, infectious disease, and neurodegenerative disease research. Its proprietary methods focus on developing therapeutic solutions by leveraging human immune-B cells, offering a cutting-edge approach to creating highly effective treatments. Adnexus Biotechnologies was founded in 2024 and is based in Dallas, Texas.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal